What is it about?

This study evaluated the perioperative complications of single-port robot-assisted radical prostatectomy (SP-RARP) using a multi-institutional database. A total of 1103 patients underwent SP-RARP between 2019 and 2022 using the purpose-built SP robotic platform. Intraoperative complications were noted in 0.4% of patients, all of which occurred during the transperitoneal approach. Postoperative complications were noted in 13% of patients with major complications (Clavien-Dindo Grade ≥III) only identified in 3.7% of the total cohort. The most common complications were lymphocele (3.9%), acute urinary retention (2%), and urinary tract infection (1.9%). The 90-day readmission rate was 3.9%. The study concluded that SP-RARP is a safe and effective procedure with low complication and readmission rates regardless of the approach.

Featured Image

Why is it important?

This research is important because it provides valuable insights into the perioperative complications of single-port robot-assisted radical prostatectomy (SP-RARP), a minimally invasive surgical technique for treating prostate cancer. Understanding the complication rates associated with SP-RARP can help guide clinical decision-making and improve patient outcomes. Key Takeaways: 1. SP-RARP is a safe and effective procedure with low complication and readmission rates. 2. The study compared three different approaches to SP-RARP: transperitoneal, extraperitoneal, and transvesical. Intraoperative complications were more common in the transperitoneal approach, while postoperative complications were relatively evenly distributed among the three approaches. 3. The most common complications were lymphocele, acute urinary retention, and urinary tract infection. 4. The 90-day readmission rate was 3.9%. 5. The study's results are comparable to current multi-port RARP literature.

AI notice

Some of the content on this page has been created using generative AI.

Read the Original

This page is a summary of: Complications of single‐port robot‐assisted radical prostatectomy: multi‐institutional analysis from the Single‐Port Advanced Research Consortium (SPARC), BJU International, December 2023, Wiley,
DOI: 10.1111/bju.16228.
You can read the full text:

Read

Contributors

Be the first to contribute to this page